Understanding the Impact of the XFG 'Stratus' Variant on UK Hospitalization Trends

The XFG variant, a recombinant SARS-CoV-2 lineage, was first identified in January 2025. The strain spread globally throughout 2025. The variant earned the nicknames American Covid and Stratus following its rapid transmission across the United States. It is now the dominant lineage in the United Kingdom. The World Health Organization (WHO) identified the strain as a recombinant of the LF.7 and LP.8.1.2 lineages.

Health authorities are working to mitigate severe outcomes and reduce the pressure on the National Health Service (NHS) as respiratory illnesses rise in the autumn of 2025. Current surveillance data shows an increase in hospital test positivity and admission rates. The UK Health Security Agency (UKHSA) reported that these figures remain lower than those recorded at the same time in 2025. Officials continue to monitor the strain. It is associated with gastrointestinal symptoms in addition to fever and fatigue.

1. The National Health Service (NHS) provides guidance to manage virus transmission. The NHS advises people who test positive to stay home for five days if they are 18 or older. Those younger than 18 should isolate for three days. This protocol aims to limit community transmission during the current rise in cases.

2. The UK Health Security Agency (UKHSA) monitors the current surge. UKHSA staff track the 7.0% hospital test positivity rate to allocate resources. Admissions in London rose by 79% during the week ending on October 2, 2026.

3. Dr. Matthew Siggins stated that no evidence suggests current UK variants cause more severe disease. Researchers compare the clinical impact of the XFG variant against earlier strains using this data.

4. Professor Paul Hunter stated that reported COVID-19 infections and hospitalizations in the United Kingdom remain lower than at this time in 2025. Admissions rose by 50% compared with the same period in 2025.

1. Professor Emma Wall stated that COVID-19 infection poses risks to clinically vulnerable adults, although the virus may be harmless for most people. The virus can cause long COVID or relapses. These outcomes remain a primary concern for vulnerable populations, regardless of the general severity of the infection.

2. The XFG variant causes gastrointestinal issues. Patients also report fever, cough, runny nose, headaches, and fatigue.

3. The UK Health Security Agency (UKHSA) reported that positive COVID-19 test rates in hospitals rose from 5.9% to 7.0% in September 2026. The virus circulated more widely in healthcare settings during that month.

4. England recorded seven deaths involving Covid-19 during the week ending May 25, 2024. Medical experts stated this figure does not indicate a significant public health crisis. The total represents an increase from the six deaths recorded the previous week.